Deltec Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Deltec Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,500	Closed	-$992K	–	169
2024 Q4	$992K	Hold	7,500	–	–	0.2%	81
2024 Q3	$1.09M	Hold	7,500	–	–	0.22%	65
2024 Q2	$1.03M	Sell	7,500 -4,000	-35%	-$534K	0.2%	80
2024 Q1	$1.58M	Sell	11,500 -1,000	-8%	-$137K	0.31%	60
2023 Q4	$1.7M	Sell	12,500 -4,100	-25%	-$500K	0.38%	59
2023 Q3	$2.03M	Hold	16,600	–	–	0.46%	50
2023 Q2	$2.11M	Sell	16,600 -4,800	-22%	-$624K	0.46%	51
2023 Q1	$2.76M	Buy	21,400 +13,400	+168%	+$1.75M	0.68%	41
2022 Q4	$1.05M	Buy	+8,000	New	+$1.03M	0.3%	65
2018 Q4	–	Sell	-5,000	Closed	-$610K	–	173
2018 Q3	$610K	Hold	5,000	–	–	0.12%	121
2018 Q2	$549K	Hold	5,000	–	–	0.11%	122
2018 Q1	$534K	Buy	+5,000	New	+$554K	0.11%	129
2017 Q2	–	Sell	-10,500	Closed	-$1.03M	–	170
2017 Q1	$1.03M	Buy	+10,500	New	+$1.01M	0.21%	96

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Deltec Asset Management's IBB Position: Q1 2025 in Review

Deltec Asset Management sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 7,500 shares — an estimated $992K sold.

Deltec Asset Management first reported a position in IBB in Q1 2017 and held it in 13 quarters. The position peaked at $2.76M in Q1 2023. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

Deltec Asset Management reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
Deltec Asset Management sold 7,500 iShares Biotechnology ETF shares in Q1 2025, an estimated $992K.
Deltec Asset Management first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 13 quarters.
Deltec Asset Management's iShares Biotechnology ETF position peaked at $2.76M in Q1 2023.
831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Deltec Asset Management's 13F filing for Q1 2025, filed 22 Apr 2025.